Next Article in Journal
Evaluation of the Results of Group B Streptococcus Screening by MALDI-TOF MS among Pregnant Women in a Hungarian Hospital
Next Article in Special Issue
High-Resolution Composition Analysis of an Inactivated Polyvalent Foot-and-Mouth Disease Vaccine
Previous Article in Journal
Endocytic Pathway of Feline Coronavirus for Cell Entry: Differences in Serotype-Dependent Viral Entry Pathway
Previous Article in Special Issue
A Rational Explanation of Limited FMD Vaccine Uptake in Endemic Regions
Article

Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis

1
Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea
2
Department of Biosystems and Bioengineering, KRIBB School of Biotechnology, University of Science and Technology, Daejeon 34113, Korea
3
Foot-and-Mouth Disease Division, Animal and Plant Quarantine Agency, Gyongsangbuk-do 39660, Korea
*
Author to whom correspondence should be addressed.
Pathogens 2019, 8(4), 301; https://doi.org/10.3390/pathogens8040301
Received: 12 November 2019 / Revised: 13 December 2019 / Accepted: 15 December 2019 / Published: 17 December 2019
Foot-and-mouth disease (FMD) is a highly contagious and economically devastating disease affecting cloven-hoofed livestock worldwide. FMD virus (FMDV) type A is one of the most common causes of FMD outbreaks among the seven FMDV serotypes, and its serological diagnosis is therefore important to confirm FMDV type A infection and to determine FMD vaccine efficacy. Here, we generated monoclonal antibodies (mAbs) specific to FMDV type A via hybridoma systems using an inactivated FMDV type A (A22/Iraq/1964) and found 4 monoclones (#29, #106, #108, and #109) with high binding reactivity to FMDV type A among 594 primary clones. In particular, the #106 mAb had a higher binding reactivity to the inactivated FMDV type A than the other mAbs and a commercial mAb. Moreover, the #106 mAb showed no cross-reactivity to inactivated FMDV type South African territories 1, 2, and 3, and low reactivity to inactivated FMDV type O (O1 Manisa). Importantly, the solid-phase competitive ELISA (SPCE) using horseradish peroxidase (HRP)-conjugated #106 mAb detected FMDV type A-specific Abs in sera from FMD type A-vaccinated cattle more effectively than a commercial SPCE. These results suggest that the newly developed FMDV type A-specific mAb might be useful for diagnostic approaches for detecting Abs against FMDV type A. View Full-Text
Keywords: foot-and-mouth disease; type A; structural protein; monoclonal antibody; solid-phase competitive ELISA; sensitivity foot-and-mouth disease; type A; structural protein; monoclonal antibody; solid-phase competitive ELISA; sensitivity
Show Figures

Figure 1

MDPI and ACS Style

Nguyen, Q.T.; Yang, J.; Byun, J.-W.; Pyo, H.M.; Park, M.-Y.; Ku, B.K.; Nah, J.; Ryoo, S.; Wee, S.-H.; Choi, K.-S.; Poo, H. Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis. Pathogens 2019, 8, 301. https://doi.org/10.3390/pathogens8040301

AMA Style

Nguyen QT, Yang J, Byun J-W, Pyo HM, Park M-Y, Ku BK, Nah J, Ryoo S, Wee S-H, Choi K-S, Poo H. Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis. Pathogens. 2019; 8(4):301. https://doi.org/10.3390/pathogens8040301

Chicago/Turabian Style

Nguyen, Quyen T.; Yang, Jihyun; Byun, Jae-Won; Pyo, Hyun M.; Park, Mi-Young; Ku, Bok K.; Nah, Jinju; Ryoo, Soyoon; Wee, Sung-Hwan; Choi, Kang-Seuk; Poo, Haryoung. 2019. "Development of Monoclonal Antibody Specific to Foot-and-Mouth Disease Virus Type A for Serodiagnosis" Pathogens 8, no. 4: 301. https://doi.org/10.3390/pathogens8040301

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop